Association between type 2 diabetes and changes in myocardial structure, contractile function, energetics, and blood flow before and after aortic valve replacement in patients with severe aortic stenosis
<strong>BACKGROUND:<br></strong> Type 2 diabetes (T2D) is associated with an increased risk of left ventricular dysfunction after aortic valve replacement (AVR) in patients with severe aortic stenosis (AS). Persistent impairments in myocardial energetics and myocardial blood flow (...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American Heart Association
2023
|
| _version_ | 1826312010827038720 |
|---|---|
| author | Jex, N Greenwood, JP Cubbon, RM Rider, OJ Chowdhary, A Thirunavukarasu, S Kotha, S Giannoudi, M McGrane, A Maccannell, A Conning-Rowland, M Straw, S Procter, H Papaspyros, S Evans, B Javangula, K Ferrara, A Elmahdy, W Kaul, P Xue, H Swoboda, P Kellman, P Valkovič, L Roberts, L Beech, D Kearney, MT Plein, S Dweck, MR Levelt, E |
| author_facet | Jex, N Greenwood, JP Cubbon, RM Rider, OJ Chowdhary, A Thirunavukarasu, S Kotha, S Giannoudi, M McGrane, A Maccannell, A Conning-Rowland, M Straw, S Procter, H Papaspyros, S Evans, B Javangula, K Ferrara, A Elmahdy, W Kaul, P Xue, H Swoboda, P Kellman, P Valkovič, L Roberts, L Beech, D Kearney, MT Plein, S Dweck, MR Levelt, E |
| author_sort | Jex, N |
| collection | OXFORD |
| description | <strong>BACKGROUND:<br></strong>
Type 2 diabetes (T2D) is associated with an increased risk of left ventricular dysfunction after aortic valve replacement (AVR) in patients with severe aortic stenosis (AS). Persistent impairments in myocardial energetics and myocardial blood flow (MBF) may underpin this observation. Using phosphorus magnetic resonance spectroscopy and cardiovascular magnetic resonance, this study tested the hypothesis that patients with severe AS and T2D (AS-T2D) would have impaired myocardial energetics as reflected by the phosphocreatine to ATP ratio (PCr/ATP) and vasodilator stress MBF compared with patients with AS without T2D (AS-noT2D), and that these differences would persist after AVR.
<br><strong>
METHODS:<br></strong>
Ninety-five patients with severe AS without coronary artery disease awaiting AVR (30 AS-T2D and 65 AS-noT2D) were recruited (mean, 71 years of age [95% CI, 69, 73]; 34 [37%] women). Thirty demographically matched healthy volunteers (HVs) and 30 patients with T2D without AS (T2D controls) were controls. One month before and 6 months after AVR, cardiac PCr/ATP, adenosine stress MBF, global longitudinal strain, NT-proBNP (N-terminal pro-B-type natriuretic peptide), and 6-minute walk distance were assessed in patients with AS. T2D controls underwent identical assessments at baseline and 6-month follow-up. HVs were assessed once and did not undergo 6-minute walk testing.
<br><strong>
RESULTS:<br></strong>
Compared with HVs, patients with AS (AS-T2D and AS-noT2D combined) showed impairment in PCr/ATP (mean [95% CI]; HVs, 2.15 [1.89, 2.34]; AS, 1.66 [1.56, 1.75]; P<0.0001) and vasodilator stress MBF (HVs, 2.11 mL min g [1.89, 2.34]; AS, 1.54 mL min g [1.41, 1.66]; P<0.0001) before AVR. Before AVR, within the AS group, patients with AS-T2D had worse PCr/ATP (AS-noT2D, 1.74 [1.62, 1.86]; AS-T2D, 1.44 [1.32, 1.56]; P=0.002) and vasodilator stress MBF (AS-noT2D, 1.67 mL min g [1.5, 1.84]; AS-T2D, 1.25 mL min g [1.22, 1.38]; P=0.001) compared with patients with AS-noT2D. Before AVR, patients with AS-T2D also had worse PCr/ATP (AS-T2D, 1.44 [1.30, 1.60]; T2D controls, 1.66 [1.56, 1.75]; P=0.04) and vasodilator stress MBF (AS-T2D, 1.25 mL min g [1.10, 1.41]; T2D controls, 1.54 mL min g [1.41, 1.66]; P=0.001) compared with T2D controls at baseline. After AVR, PCr/ATP normalized in patients with AS-noT2D, whereas patients with AS-T2D showed no improvements (AS-noT2D, 2.11 [1.79, 2.43]; AS-T2D, 1.30 [1.07, 1.53]; P=0.0006). Vasodilator stress MBF improved in both AS groups after AVR, but this remained lower in patients with AS-T2D (AS-noT2D, 1.80 mL min g [1.59, 2.0]; AS-T2D, 1.48 mL min g [1.29, 1.66]; P=0.03). There were no longer differences in PCr/ATP (AS-T2D, 1.44 [1.30, 1.60]; T2D controls, 1.51 [1.34, 1.53]; P=0.12) or vasodilator stress MBF (AS-T2D, 1.48 mL min g [1.29, 1.66]; T2D controls, 1.60 mL min g [1.34, 1.86]; P=0.82) between patients with AS-T2D after AVR and T2D controls at follow-up. Whereas global longitudinal strain, 6-minute walk distance, and NT-proBNP all improved after AVR in patients with AS-noT2D, no improvement in these assessments was observed in patients with AS-T2D.
<br><strong>
CONCLUSIONS:<br></strong>
Among patients with severe AS, those with T2D demonstrate persistent abnormalities in myocardial PCr/ATP, vasodilator stress MBF, and cardiac contractile function after AVR; AVR effectively normalizes myocardial PCr/ATP, vasodilator stress MBF, and cardiac contractile function in patients without T2D. |
| first_indexed | 2024-03-07T08:21:17Z |
| format | Journal article |
| id | oxford-uuid:2edf515d-70ab-442c-a269-edeec94b6a02 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T08:21:17Z |
| publishDate | 2023 |
| publisher | American Heart Association |
| record_format | dspace |
| spelling | oxford-uuid:2edf515d-70ab-442c-a269-edeec94b6a022024-02-02T10:59:46ZAssociation between type 2 diabetes and changes in myocardial structure, contractile function, energetics, and blood flow before and after aortic valve replacement in patients with severe aortic stenosisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:2edf515d-70ab-442c-a269-edeec94b6a02EnglishSymplectic ElementsAmerican Heart Association2023Jex, NGreenwood, JPCubbon, RMRider, OJChowdhary, AThirunavukarasu, SKotha, SGiannoudi, MMcGrane, AMaccannell, AConning-Rowland, MStraw, SProcter, HPapaspyros, SEvans, BJavangula, KFerrara, AElmahdy, WKaul, PXue, HSwoboda, PKellman, PValkovič, LRoberts, LBeech, DKearney, MTPlein, SDweck, MRLevelt, E<strong>BACKGROUND:<br></strong> Type 2 diabetes (T2D) is associated with an increased risk of left ventricular dysfunction after aortic valve replacement (AVR) in patients with severe aortic stenosis (AS). Persistent impairments in myocardial energetics and myocardial blood flow (MBF) may underpin this observation. Using phosphorus magnetic resonance spectroscopy and cardiovascular magnetic resonance, this study tested the hypothesis that patients with severe AS and T2D (AS-T2D) would have impaired myocardial energetics as reflected by the phosphocreatine to ATP ratio (PCr/ATP) and vasodilator stress MBF compared with patients with AS without T2D (AS-noT2D), and that these differences would persist after AVR. <br><strong> METHODS:<br></strong> Ninety-five patients with severe AS without coronary artery disease awaiting AVR (30 AS-T2D and 65 AS-noT2D) were recruited (mean, 71 years of age [95% CI, 69, 73]; 34 [37%] women). Thirty demographically matched healthy volunteers (HVs) and 30 patients with T2D without AS (T2D controls) were controls. One month before and 6 months after AVR, cardiac PCr/ATP, adenosine stress MBF, global longitudinal strain, NT-proBNP (N-terminal pro-B-type natriuretic peptide), and 6-minute walk distance were assessed in patients with AS. T2D controls underwent identical assessments at baseline and 6-month follow-up. HVs were assessed once and did not undergo 6-minute walk testing. <br><strong> RESULTS:<br></strong> Compared with HVs, patients with AS (AS-T2D and AS-noT2D combined) showed impairment in PCr/ATP (mean [95% CI]; HVs, 2.15 [1.89, 2.34]; AS, 1.66 [1.56, 1.75]; P<0.0001) and vasodilator stress MBF (HVs, 2.11 mL min g [1.89, 2.34]; AS, 1.54 mL min g [1.41, 1.66]; P<0.0001) before AVR. Before AVR, within the AS group, patients with AS-T2D had worse PCr/ATP (AS-noT2D, 1.74 [1.62, 1.86]; AS-T2D, 1.44 [1.32, 1.56]; P=0.002) and vasodilator stress MBF (AS-noT2D, 1.67 mL min g [1.5, 1.84]; AS-T2D, 1.25 mL min g [1.22, 1.38]; P=0.001) compared with patients with AS-noT2D. Before AVR, patients with AS-T2D also had worse PCr/ATP (AS-T2D, 1.44 [1.30, 1.60]; T2D controls, 1.66 [1.56, 1.75]; P=0.04) and vasodilator stress MBF (AS-T2D, 1.25 mL min g [1.10, 1.41]; T2D controls, 1.54 mL min g [1.41, 1.66]; P=0.001) compared with T2D controls at baseline. After AVR, PCr/ATP normalized in patients with AS-noT2D, whereas patients with AS-T2D showed no improvements (AS-noT2D, 2.11 [1.79, 2.43]; AS-T2D, 1.30 [1.07, 1.53]; P=0.0006). Vasodilator stress MBF improved in both AS groups after AVR, but this remained lower in patients with AS-T2D (AS-noT2D, 1.80 mL min g [1.59, 2.0]; AS-T2D, 1.48 mL min g [1.29, 1.66]; P=0.03). There were no longer differences in PCr/ATP (AS-T2D, 1.44 [1.30, 1.60]; T2D controls, 1.51 [1.34, 1.53]; P=0.12) or vasodilator stress MBF (AS-T2D, 1.48 mL min g [1.29, 1.66]; T2D controls, 1.60 mL min g [1.34, 1.86]; P=0.82) between patients with AS-T2D after AVR and T2D controls at follow-up. Whereas global longitudinal strain, 6-minute walk distance, and NT-proBNP all improved after AVR in patients with AS-noT2D, no improvement in these assessments was observed in patients with AS-T2D. <br><strong> CONCLUSIONS:<br></strong> Among patients with severe AS, those with T2D demonstrate persistent abnormalities in myocardial PCr/ATP, vasodilator stress MBF, and cardiac contractile function after AVR; AVR effectively normalizes myocardial PCr/ATP, vasodilator stress MBF, and cardiac contractile function in patients without T2D. |
| spellingShingle | Jex, N Greenwood, JP Cubbon, RM Rider, OJ Chowdhary, A Thirunavukarasu, S Kotha, S Giannoudi, M McGrane, A Maccannell, A Conning-Rowland, M Straw, S Procter, H Papaspyros, S Evans, B Javangula, K Ferrara, A Elmahdy, W Kaul, P Xue, H Swoboda, P Kellman, P Valkovič, L Roberts, L Beech, D Kearney, MT Plein, S Dweck, MR Levelt, E Association between type 2 diabetes and changes in myocardial structure, contractile function, energetics, and blood flow before and after aortic valve replacement in patients with severe aortic stenosis |
| title | Association between type 2 diabetes and changes in myocardial structure, contractile function, energetics, and blood flow before and after aortic valve replacement in patients with severe aortic stenosis |
| title_full | Association between type 2 diabetes and changes in myocardial structure, contractile function, energetics, and blood flow before and after aortic valve replacement in patients with severe aortic stenosis |
| title_fullStr | Association between type 2 diabetes and changes in myocardial structure, contractile function, energetics, and blood flow before and after aortic valve replacement in patients with severe aortic stenosis |
| title_full_unstemmed | Association between type 2 diabetes and changes in myocardial structure, contractile function, energetics, and blood flow before and after aortic valve replacement in patients with severe aortic stenosis |
| title_short | Association between type 2 diabetes and changes in myocardial structure, contractile function, energetics, and blood flow before and after aortic valve replacement in patients with severe aortic stenosis |
| title_sort | association between type 2 diabetes and changes in myocardial structure contractile function energetics and blood flow before and after aortic valve replacement in patients with severe aortic stenosis |
| work_keys_str_mv | AT jexn associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT greenwoodjp associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT cubbonrm associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT rideroj associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT chowdharya associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT thirunavukarasus associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT kothas associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT giannoudim associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT mcgranea associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT maccannella associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT conningrowlandm associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT straws associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT procterh associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT papaspyross associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT evansb associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT javangulak associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT ferraraa associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT elmahdyw associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT kaulp associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT xueh associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT swobodap associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT kellmanp associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT valkovicl associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT robertsl associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT beechd associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT kearneymt associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT pleins associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT dweckmr associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis AT levelte associationbetweentype2diabetesandchangesinmyocardialstructurecontractilefunctionenergeticsandbloodflowbeforeandafteraorticvalvereplacementinpatientswithsevereaorticstenosis |